NeuroPET™ for neurological research

The NeuroPET™ scanner uses low doses of 18F and 11C radiotracers to generate detailed images of the human brain. These radiotracers are known to be helpful in imaging metabolism, amyloid, and dopaminergic binding in neurological diseases such as Alzheimer’s, Parkinson’s, neuro-oncology, and neuropsychiatric disorders. NeuroPET's capabilities enable ultra high-sensitivity molecular imaging of the brain with minimal exposure to the subject or the technologist. This means safer repeat scans for longitudinal studies and monitoring treatment response in drug trials for a wide variety of neurological diseases.

Because NeuroPET™ components are compact and require virtually no specialized infrastructure, state-of-the-art neurological imaging is now available in the research environment at far lower cost than with whole body scanners.